Venture capital firm

Anthill Ventures

Indian venture investor backing urban-technology entrepreneurs with capital and help scaling their products

Visit Website Get introducedRequest an introduction Write a Review

TrustList summary

Anthill Ventures, also referred to as Anthill Capital Ventures, is an India-based venture investor focused on urban technology. It backs entrepreneurs building products for cities, and it works with founders on growth as well as funding.

What Anthill Ventures offers

Venture investment: puts capital into early-stage urban-tech companies.
Scaling support: helps portfolio companies expand into new geographies and win larger customers.
Programme partnerships: backed a research and development incubator for sustainable cities run by URB, a Dubai-based company.

Clients

Entrepreneurs in the urban technology space, including firms working on smart, sustainable and citizen-responsive cities. Its portfolio has served both business and government clients.

Key facts

Based in: India
Focus: Urban technology and sustainable cities
Partnership: Announced a 2022 agreement with the URB incubator in Dubai

Summary written by TrustList from the business's own published information, Oct 2026.

Gallery

2 images - click to enlarge

Categories & features

Rankings

Anthill Ventures is ranked on 4 TrustList rankings: #4 on 1, #24 on 1, #27 on 1 and #31 on 1.

Every ranking orders its listings by their reviews, how complete the profile is and the Trust Score. Anthill Ventures has no reviews yet and 3 of the 10 profile details we look for. Where no listing on a page has been reviewed, the order follows the profiles alone.

Venture capital firm · 4 rankings

#4of 17
Consumer investors
It is one of 2 here listing biotech and one of 4 here listing growth stage.
Of the 17 here, 5 also cover seed stage and 4 also cover growth stage; 2 also work in San Francisco and 2 also work in London.
Behind Kaedan Capital, ahead of Moxxie Ventures.
#24of 79
Biotech investors
It is one of 2 here listing consumer and one of 9 here listing seed stage.
Of the top 65 here, 22 also cover healthtech and 17 also cover science; 14 also work in Boston and 8 also work in New York City.
Behind Ampersand Capital Partners, ahead of Apposite Capital.
#27of 92
Singapore
It is one of 5 here listing series a.
Of the top 66 here, 11 also cover partners and 8 also cover private equity; 16 also work in Hong Kong and 12 also work in Tokyo.
Behind Alterdice, ahead of Arcane Group.
#31of 130
Growth stage
It is one of 2 here listing consumer and one of 5 here listing biotech.
Of the top 69 here, 18 also cover artificial intelligence and 8 also cover series a; 11 also work in Silicon Valley and 6 also work in Chicago.
Behind Anicut Capital, ahead of Baird Capital.